Post by
fdfd12 on Jan 12, 2016 10:58am
STOCKCOACH
What I am saying is that CXR is computer traded to the tune of the IBB.
If IBB ticks up, then computers start buying CXR and others in the IBB.
Is disassociates itself from the iBB at earnings time and when there is an upgrade.
Otherwise, computers buy CXR and others with up and down ticks of IBB
Comment by
argentia77 on Jan 12, 2016 12:30pm
Faulty logic. Why would anything be different if CXR wasn't included in IBB basket? Nothing actually. Algos and computers could just as easily buy and sell CXR when IBB upticks or downticks whether or not it is included in the IBB portfolio. You might as well say that because all apples are fruits, then all fruits must be apples!
Comment by
fdfd12 on Jan 12, 2016 1:13pm
Well argentina, just look at the minute action. Put on chart IBB against the other CXR. After you do that, tell me that I am wrong. BUT LOOK FIRST please. I am tellin you, that is what is happening. Look please at the two charts. please
Comment by
argentia77 on Jan 12, 2016 2:09pm
That correlation is not because CXR is included in the IBB portfolio which is what you were saying in previous posts. It could be similarly correlated to the extent it is even if CXR was only trading in Canada. High speed computer trading and algos don't discriminate. Look at any other health care peer not included in IBB and you'll find similar correlation.
Comment by
fdfd12 on Jan 12, 2016 2:16pm
I agree but it still means that CXR is only as good as IBB. If IBB doesn't go anywhere this year, CXR won't do what we expect it to do.
Comment by
Investor198 on Jan 12, 2016 4:45pm
Stockcoach1 - I totally agree with you on this one. It is market sentiment right now - people using their emotions rather than using their head
Comment by
Slinger14 on Jan 12, 2016 5:06pm
I don't know what's so hard to understand about this. The stocks within IBB determine it's price, not the other way around. If somebody can't understand this, they don't have a very good understanding of the stock market in general.
Comment by
adamchess on Jan 12, 2016 1:00pm
Well, I think that IBB is one of the best to be associated with historically last five years. Short-term Hillary is having effect, but misguided against R&D companies such as Celgene, etc. IBB and CXR will rebound soon.